References
- Feng, D., Lindpaintner, K., Larson, M.G., Rao, V.S., O'Donnell, C.J., Lipinska, I., Schmitz, C., Sutherland, P.A., Silbershatz, H., D'Agostino, R.B., Muller, J.E., Myers, R.H., Levy, D., Tofler, G.H. (1999). Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol., 19, 1142-1147.
- Goodall, A.H., Curzen, N., Panesar, M., Hurd, C., Knight, C.J., Ouwehand, W.H., Fox, K.M. (1999). Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur. Heart J., 20, 742-747.
- Honda, S., Honda, Y., Bauer, B., Ruan, C., Kunicki, T.J. (1995). The impact of three-dimensional structure on the expression of PlA alloantigens on human integrin beta 3. Blood, 86, 234-242.
- Kastrati, A., Koch, W., Gawaz, M., Mehilli, J., Bottiger, C., Schomig, K., von Beckerath, N., Schomig, A. (2000). P1A polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J. Amer. Coll. Cardiol., 36, 84-89.
- Kim, S., Ruparel, H.D., Gilliam, T.C., Ju, J. (2003). Digital genotyping using molecular affinity and mass spectrometry. Nat. Rev. Genet., 4, 1001-1008.
- Kunicki, T.J., Honda, S., Dawson, B., Honda, Y., Ruan, C., Aster, R.H. (1995). The P1A alloantigen system is a sensitive indicator of the structural integrity of the amino-terminal domain of the human integrin beta 3 sub-unit. Blood Cells Mol. Dis., 21, 131-141.
- Līcis, N., Krivmane, B., Berzina, M., Zabunova, M., Latkovskis, G. (2006). A radical mutation in the GPIIIA gene of a patient with myocardial infarction. Proc. Latvian Acad. Sci. Section B, 60, 140-141.
- Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B., de Faire, U. (1994). Genetic susceptibility to death from coronary heart disease in a study of twins. New. Engl. J. Med., 330, 1041-1046.
- Michelson, A.D., Furman, M.I., Goldschmidt-Clermont, P., Mascelli, M.A., Hendrix, C., Coleman, L., Hamlington, J., Barnard, M.R., Kickler, T., Christie, D.J., Kundu, S., Bray, P.F. (2000). Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation, 101, 1013-1018.
- Mikkelsson, J., Perola, M., Karhunen, P.J. (2005). Genetics of platelet glycoprotein receptors: Risk of thrombotic events and pharmacogenetic implications. Clin. Appl. Thromb. Hemost., 11, 113-125.
- Mikkelsson, J., Perola, M., Penttila, A., Goldschmidt-Clermont, P.J., Karhunen, P.J. (2001). The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis. Atherosclerosis, 154, 721-727.
- Nadasi, E., Bene, J., Havasi, V., Komlosi, K., Talian, G., Melegh, G., Papp, E., Gasztonyi, B., Szolnoki, Z., Sandor, J., Mozsik, G., Toth, K., Melegh, B., Wittmann, I. (2005). Detection of the Leu40Arg variant of the platelet glycoprotein IIb/IIIa receptor in subjects with thrombotic diseases. Thromb. Res., 116, 479-482.
- Newman, P.J., Derbes, R.S., Aster, R.H. (1989). The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J. Clin. Invest., 83, 1778-1781.
- Unkelbach, K., Kalb, R., Breitfeld, C., Santoso, S., Kiefel, V., Mueller-Eckhardt, C. (1994). New polymorphism on platelet glycoprotein IIIa gene recognized by endonuclease Msp I: Implications for PlA typing by allele-specific restriction analysis. Transfusion, 34, 592-595.
- Vijayan, K.V., Goldschmidt-Clermont, P.J., Roos, C., Bray, P.F. (2000). The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J. Clin. Invest., 105, 793-802.
- Weiss, E.J., Bray, P.F., Tayback, M., Schulman, S.P., Kickler, T.S., Becker, L.C., Weiss, J.L., Gerstenblith, G., Goldschmidt-Clermont, P.J. (1996). A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New. Engl. J. Med., 334, 1090-1094.